Funding · Company
Strand Therapeutics Inc.
Boston, MABiotech & Pharma
Strand Therapeutics Inc. of Boston, MA has disclosed $160M across 2 Form D offerings filed with the SEC between Jul 27, 2021 and Mar 17, 2026.
$160M
Total disclosed
2
Form D offerings
2017
Incorporated
This CIK has filed under more than one name: Strand Therapeutics Inc., STRAND THERAPEUTICS INC. We use the most recent.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$108M
Form D · Mar 17, 2026 ↗
Q1 2026
· target $120M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2017SEC CIK0001778475Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →